Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amodiaquine agranulocytosis

P Gillespie, F Wagner

    The Medical Journal of Australia
    |February 26, 1977
    PubMed
    Summary

    Amodiaquine, an antimalarial drug, can cause severe neutropenia (low white blood cell count) and infection, even at recommended doses for malaria prevention.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Magnetic resonance imaging in gustatory disorders: diagnostic usefulness with a cost analysis.

    Rhinology·2025
    Same author

    Antimicrobial Stewardship in German non-university hospitals: baseline status and impact of a multifaceted AMS intervention within the prospective ID ROLL OUT study.

    Infection·2025
    Same author

    7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine.

    European journal of neurology·2025
    Same author

    Optimal Operation of Cryogenic Calorimeters Through Deep Reinforcement Learning.

    Computing and software for big science·2024
    Same author

    Supporting GPs and people with hypertension to maximise medication use to control blood pressure: a pilot cluster RCT of the MIAMI intervention.

    BMC primary care·2024
    Same author

    Under-reporting of forensic findings: craniocervical emergency imaging in cases of survived hanging.

    Forensic science, medicine, and pathology·2023

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Hematology

    Background:

    • Amodiaquine is a widely used antimalarial drug.
    • Malaria prophylaxis aims to prevent malaria infection.

    Observation:

    • This case report details a patient who developed profound neutropenia and severe infection.
    • The patient received the recommended dose of amodiaquine for malaria prophylaxis.

    Findings:

    • Administration of amodiaquine, even at recommended prophylactic doses, can lead to severe adverse events.
    • Profound neutropenia is a critical side effect associated with amodiaquine use.

    Implications:

    • Healthcare providers should be vigilant for signs of neutropenia and infection in patients taking amodiaquine.
    • This case highlights the importance of monitoring patients for potential severe adverse drug reactions.
    • Further research may be warranted to assess the risk-benefit profile of amodiaquine in specific populations.